Form D · Biotechnology

Magnendo Corp.

Newton, MA · CIK 0002026763

Offering snapshot reported Jul 29, 2026 · SEC filing

Reported sold
$18M
Offering amount: $18M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 17, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 29, 2026Initial$18,000,000No comparison10SEC filing
Oct 23, 2024Amendment$2,254,999$785,000vs Jun 20, 202437SEC filing
Jun 20, 2024Initial$1,469,999No comparison31SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-592521

Source: Form D, filed Jul 29, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jeffrey Arnold Director
Yoonho Kim Director, Executive
Aman Patel Director
Meir Rosenberg Executive
Xuanhe Zhao Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
300 Washington Street Suite 150
Newton, MA, 02458
Phone: 617-852-3504